Frymoyer, A., Schwenk, H. T., Brockmeyer, J. M., & Bio, L. (2023). Impact of model‐informed precision dosing on achievement of vancomycin exposure targets in pediatric patients with cystic fibrosis. Pharmacotherapy, 43(10), 1007. https://doi.org/10.1002/phar.2845
Chicago Style (17th ed.) CitationFrymoyer, Adam, Hayden T. Schwenk, Jake M. Brockmeyer, and Laura Bio. "Impact of Model‐informed Precision Dosing on Achievement of Vancomycin Exposure Targets in Pediatric Patients with Cystic Fibrosis." Pharmacotherapy 43, no. 10 (2023): 1007. https://doi.org/10.1002/phar.2845.
MLA (9th ed.) CitationFrymoyer, Adam, et al. "Impact of Model‐informed Precision Dosing on Achievement of Vancomycin Exposure Targets in Pediatric Patients with Cystic Fibrosis." Pharmacotherapy, vol. 43, no. 10, 2023, p. 1007, https://doi.org/10.1002/phar.2845.